Kristen Sanfilippo/X
Jun 22, 2025, 12:53
Kristen Sanfilippo: Time to Anticoagulants Therapy is a Modifiable Risk Factor for PE-associated Mortality
Kristen Sanfilippo, Hematologist in the Division of Hematology at Washington University School of Medicine, shared a post on X:
“Time to Anticoagulants therapy is a modifiable risk factor for PE-associated mortality.
- Big weekend for Kelsey Bria
- Finished Residency
- Started Fellowship as our newest ASH HFFTP
- First Oral “
More posts from ISTH 2025 on Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025